Affordable Access

Publisher Website

Cholangiocarcinoma

Authors
Journal
The Lancet
0140-6736
Publisher
Elsevier
Volume
383
Issue
9935
Identifiers
DOI: 10.1016/s0140-6736(13)61903-0
Keywords
  • Review And Opinion
  • Seminar
Disciplines
  • Medicine

Abstract

Summary Cholangiocarcinoma represents a diverse group of epithelial cancers united by late diagnosis and poor outcomes. Specific diagnostic and therapeutic approaches are undertaken for cholangiocarcinomas of different anatomical locations (intrahepatic, perihilar, and distal). Mixed hepatocellular cholangiocarcinomas have emerged as a distinct subtype of primary liver cancer. Clinicians need to be aware of intrahepatic cholangiocarcinomas arising in cirrhosis and properly assess liver masses in this setting for cholangiocarcinoma. Management of biliary obstruction is obligatory in perihilar cholangiocarcinoma, and advanced cytological tests such as fluorescence in-situ hybridisation for aneusomy are helpful in the diagnosis. Liver transplantation is a curative option for selected patients with perihilar but not with intrahepatic or distal cholangiocarcinoma. International efforts of clinicians and scientists are helping to identify the genetic drivers of cholangiocarcinoma progression, which will unveil early diagnostic markers and direct development of individualised therapies.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Cholangiocarcinoma.

on Nature clinical practice. Gast... January 2006

Cholangiocarcinoma

on Digestive Diseases and Science... May 01, 1988

Hilar cholangiocarcinoma.

on World journal of gastrointesti... Jul 15, 2013

Genes and cholangiocarcinoma.

on The Southeast Asian journal of... July 2009
More articles like this..